ELUTIA INC.

ELUT

ELUTIA INC.

ELUT

Insider Sentiment (TTM):

Last Purchase:2026-01-30Last Sale:2023-03-09Shares Purchased (TTM):295,000Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:15,175,371Shares Outstanding:42,998,504Institutional Ownership Pct.:35.29%

Earnings Market Reaction:

Filing Date:2026-08-14Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	20	28	36	5	9	17	13	26	18	13	19	15
Accounts Receivable Net Current	1	2	2	4	3	3	2	3	4	4	3	3
Inventory Net	3	3	3	2	5	4	2	4	3	3	4	7
Loss Contingency Receivable Current	4	5	5	5	4	4	5	5	4	2	3	7
Prepaid Expense And Other Assets Current	1	2	2	1	1	2	2	0	1	2	2	0
Assets Of Disposal Group Including Discontinued Op…	-	-	-	3	-	-	2	-	-	-	-	7
Assets Current	37	49	56	18	22	30	26	37	30	24	31	39
Property Plant And Equipment Net	3	3	3	2	2	1	1	1	0	0	0	0
Intangible Assets Net Excluding Goodwill	1	1	2	2	7	7	3	9	10	11	12	13
Other Assets Noncurrent	3	2	2	3	3	1	0	1	1	0	0	0
Disposal Group Including Discontinued Operation As…	-	-	-	5	-	-	7	-	-	-	-	3
Assets	44	55	62	29	34	39	36	48	42	35	43	55
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	4	4	5	7	6	5	4	5	3	4	3	3
Accrued Liabilities Current	5	6	4	7	6	6	7	5	7	9	9	11
Short Term Borrowings	-	-	-	5	4	3	1	-	3	2	3	-
Litigation Reserve Current	6	8	11	16	17	18	20	24	20	16	15	16
Other Liabilities Current	1	1	0	0	0	0	0	0	0	0	0	0
Liabilities Of Disposal Group Including Discontinu…	-	-	-	0	-	-	0	-	-	-	-	3
Liabilities Current	21	24	25	41	38	37	38	40	40	38	43	45
Long Term Debt Noncurrent	-	-	-	21	21	22	23	23	19	20	20	25
Warrants And Rights Outstanding	3	3	3	4	9	12	16	19	39	20	13	8
Other Liabilities Noncurrent	-	-	-	-	-	-	-	2	2	1	1	0
Operating Lease Liability Noncurrent	4	4	4	3	3	0	0	-	-	-	-	-
Liabilities Of Disposal Group Including Discontinu…	-	-	-	0	-	-	0	-	-	-	-	1
Liabilities	28	33	35	73	76	76	82	89	106	86	82	84
Stockholders Equity
Additional Paid In Capital	207	206	204	203	201	197	183	180	157	143	137	137
Retained Earnings Accumulated Deficit	-191	-184	-176	-247	-243	-234	-230	-221	-222	-194	-176	-166
Stockholders Equity	16	23	28	-44	-42	-36	-46	-40	-64	-50	-39	-29
Liabilities And Stockholders Equity	44	55	62	29	34	39	36	48	42	35	43	55
Notes And Loans Receivable Net Current	-	-	-	-	-	-	-	-	-	-	-	1
Common Class A	-	44	43	2	2	37	31	6	24	-4	19	7
Common Class B	-	0	0	-2	0	4	4	0	4	0	4	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-3.01%	-9.51%	-12.14%	-	-	-	-	-	-	-	-	-
2025	0.00%	10.00%	7.37%	-12.56%	-59.07%	-57.72%	-6.22%	-13.11%	41.89%	8.33%	-6.48%	7.41%
2024	-0.29%	33.63%	-12.57%	38.94%	23.61%	4.04%	14.62%	-9.92%	-15.93%	-0.37%	-25.00%	-33.82%
2023	-	-	-	-	-	-	22.70%	108.59%	122.70%	-7.48%	-8.72%	1.25%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	1.77	2.05	2.22	0.44	0.59	0.81	0.69	0.94	0.76	0.63	0.73	0.87
Quick Ratio	1.58	1.85	2.03	0.38	0.42	0.65	0.59	0.84	0.66	0.50	0.59	0.72
Working Capital	16.17M	24.87M	30.68M	-22.96M	-15.67M	-6.83M	-11.62M	-2.36M	-9.46M	-14.08M	-11.78M	-5.61M
Leverage & Debt
Debt to Equity	1.77	1.45	1.25	-1.67	-1.81	-2.08	-1.78	-2.20	-1.65	-1.70	-2.13	-2.85
Interest Coverage TTM	-63.91	-29.72	-14.41	-6.33	-7.59	-6.37	-6.43	-8.45	-6.06	-5.40	-5.27	-5.66
Debt Ratio	0.64	0.59	0.56	2.49	2.24	1.93	2.28	1.83	2.54	2.42	1.89	1.54
Efficiency & Turnover
Asset Turnover TTM	0.31	0.26	0.25	0.18	0.19	0.29	0.36	0.44	0.53	0.52	0.44	0.22
Days Sales Outstanding TTM	68.99	72.20	59.53	172.98	169.49	123.65	69.87	47.11	71.83	85.54	51.90	143.89
Receivables Turnover TTM	5.29	5.06	6.13	2.11	2.15	2.95	5.22	7.75	5.08	4.27	7.03	2.54
Per Share Metrics
Diluted EPS TTM	1.17	1.16	1.16	-0.56	-0.46	-0.93	-1.86	-1.53	-2.62	-1.99	-2.07	-1.99
Free Cash Flow Per Share TTM	-1.08	-1.07	-1.14	-0.58	-0.60	-0.77	-0.80	-0.62	-0.85	-0.81	-1.22	-1.08
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	57.76%	56.33%	53.66%	58.03%	54.43%	48.99%	46.42%	42.43%	42.45%	42.01%	44.67%	66.34%
Operating Profit Margin TTM	-214.85%	-212.60%	-218.91%	-363.95%	-402.02%	-270.51%	-212.29%	-153.94%	-131.54%	-122.43%	-123.36%	-260.16%
Net Profit Margin TTM	426.90%	400.16%	434.23%	-386.96%	-296.91%	-371.95%	-372.91%	-240.66%	-261.08%	-190.35%	-152.18%	-265.23%
Growth Metrics
Net Revenue Growth (1Y)	69.03%	16.15%	-15.03%	-69.63%	-71.27%	-57.18%	-41.54%	76.82%	100.55%	33.61%	3.76%	-68.81%
Net Income Growth (1Y)	-343.02%	-224.96%	-198.95%	-51.16%	-67.32%	-16.34%	43.27%	60.45%	92.18%	45.70%	14.47%	-7.50%
EPS Growth (1Y)	-329.61%	-212.22%	-169.45%	-62.57%	-80.53%	-48.19%	-10.50%	-16.04%	25.22%	-1.60%	-12.81%	-25.75%
Valuation Metrics
P/E TTM	0.84	0.91	0.54	-1.43	-3.88	-2.45	-2.02	-2.29	-1.89	-1.58	-1.04	-0.72
P/B TTM	2.75	2.00	1.04	-0.86	-1.98	-2.68	-2.35	-3.08	-1.92	-1.50	-1.02	-0.83
P/S TTM	3.57	3.62	2.33	5.52	11.52	9.11	7.52	5.50	4.94	3.01	1.59	1.91
Market Cap	43.34M	45.15M	28.70M	37.76M	82.73M	97.70M	108.73M	123.90M	123.50M	75.32M	39.23M	24.34M
Enterprise Value	23.44M	16.66M	22.93M	59.15M	99.35M	104.60M	119.34M	120.80M	127.64M	84.78M	43.63M	35.10M
Calculated Values
Free Cash Flow TTM	-47.63M	-46.15M	-47.01M	-24.54M	-25.00M	-29.82M	-23.32M	-20.06M	-21.28M	-19.42M	-22.11M	-18.39M
Net Debt	-19.90M	-28.49M	-5.77M	21.38M	16.62M	6.90M	10.61M	-3.10M	4.13M	9.46M	4.40M	10.76M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-01-30Purchase

Owner: Neels, Guido J

Title: -

Shares: 20,000

Price/Share: $1.04

Value: $20,800.00

Shares Owned: 118,750

Relationship: Director

Ownership: Direct

2026-01-30Purchase

Owner: Rakin, Kevin, Highcape Pa…

Title: -

Shares: 70,000

Price/Share: $1.06

Value: $74,200.00

Shares Owned: 196,120

Relationship: TenPercentOwner

Ownership: Direct

2026-01-29Purchase

Owner: Neels, Guido J

Title: -

Shares: 15,000

Price/Share: $1.06

Value: $15,900.00

Shares Owned: 98,750

Relationship: Director

Ownership: Direct

2025-12-17Purchase

Owner: Mills, C Randal

Title: PRESIDENT AND CEO

Shares: 3,000

Price/Share: $0.51

Value: $1,530.00

Shares Owned: 379,204

Relationship: Director,Officer

Ownership: Direct

2025-12-17Purchase

Owner: Makes, Brigid

Title: -

Shares: 25,000

Price/Share: $0.52

Value: $13,000.00

Shares Owned: 27,000

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-01-30	Neels, Guido J	Director	-	Direct	Purchase	20,000	1.04	$20,800.00	118,750	4
2026-01-30	Rakin, Kevin, Highcape Pa…	TenPercentOwner	-	Direct	Purchase	70,000	1.06	$74,200.00	196,120	4
2026-01-29	Neels, Guido J	Director	-	Direct	Purchase	15,000	1.06	$15,900.00	98,750	4
2025-12-17	Mills, C Randal	Director,Officer	PRESIDENT AND CEO	Direct	Purchase	3,000	0.51	$1,530.00	379,204	4
2025-12-17	Makes, Brigid	Director	-	Direct	Purchase	25,000	0.52	$13,000.00	27,000	4
2025-12-17	Ferguson, Matthew	Officer	CHIEF FINANCIAL OFFICER	Direct	Purchase	60,000	0.53	$31,800.00	447,110	4
2025-12-17	Highcape, Partners Gp Ii,…	TenPercentOwner	-	Indirect	Purchase	50,000	0.52	$26,000.00	322,419	4
2025-12-17	Colpman, David	Director	-	Direct	Purchase	12,500	0.51	$6,375.00	31,098	4
2025-12-02	Ferguson, Matthew	Officer	CHIEF FINANCIAL OFFICER	Direct	Purchase	5,500	0.67	$3,685.00	379,071	4
2025-11-24	Mills, C Randal	Director,Officer	PRESIDENT AND CEO	Direct	Purchase	5,000	0.60	$3,000.00	358,785	4
2025-11-17	Colpman, David	Director	-	Direct	Purchase	15,500	0.74	$11,470.00	18,598	4
2025-11-13	Mills, C Randal	Director,Officer	PRESIDENT AND CEO	Direct	Purchase	13,500	0.75	$10,125.00	353,785	4
2025-02-03	Highcape, Partners, L.P.,…	TenPercentOwner	-	Indirect	Purchase	420,000	2.50	$1,050,000.00	9,520,232	4
2025-02-03	Highcape, Capital, L.P., …	TenPercentOwner	-	Indirect	Purchase	420,000	2.50	$1,050,000.00	9,520,232	4
2023-03-27	Birchview, Fund Llc, Birc…	Other	-	Indirect	Purchase	10,000	1.59	$15,900.00	1,655,184	4/A
2023-03-27	Birchview, Capital, Lp, B…	TenPercentOwner	-	Indirect	Purchase	10,000	1.59	$15,900.00	1,655,184	4
2023-03-09	Englese, Thomas	Officer	CHIEF COMMERCIAL OFFICER	Direct	Sale	289	4.30	$1,242.70	17,917	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

35.29%

Inst. Shares: 15,175,371

Shares Outstanding: 42,998,504

2025-12-31

38.60%

Inst. Shares: 15,988,325

Shares Outstanding: 41,416,850

2025-09-30

42.41%

Inst. Shares: 17,996,146

Shares Outstanding: 42,431,314

2025-06-30

41.57%

Inst. Shares: 17,369,511

Shares Outstanding: 41,782,556

2025-03-31

44.58%

Inst. Shares: 17,214,569

Shares Outstanding: 38,616,207

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	15,175,371	42,998,504	35.29%
2025-12-31	15,988,325	41,416,850	38.60%
2025-09-30	17,996,146	42,431,314	42.41%
2025-06-30	17,369,511	41,782,556	41.57%
2025-03-31	17,214,569	38,616,207	44.58%
2024-12-31	13,185,515	29,071,113	45.36%
2024-09-30	12,190,931	32,520,134	37.49%
2024-06-30	8,195,497	24,900,167	32.91%
2024-03-31	4,858,021	23,912,326	20.32%
2023-12-31	6,058,629	18,160,822	33.36%
2023-09-30	6,218,037	17,017,610	36.54%
2023-06-30	2,594,293	16,223,919	15.99%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

ELUTIA INC. (ELUT) — SEC Financial Statements & Analysis

ELUTIA INC. (ELUT) is a biological products, (no diagnostic substances) company, incorporated in DE. ELUTIA INC. trades on Nasdaq as: ELUT. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), ELUTIA INC. reported a 69.03% year-over-year revenue growth, a Gross Profit Margin of 57.76% (TTM), a Debt-to-Equity ratio of 1.77x, a Price-to-Sales (P/S) ratio of 3.57x (TTM), a Price-to-Book (P/B) ratio of 2.75x (TTM), at a market cap of $43.34M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 69.03%
Gross Profit Margin TTM: 57.76%
Debt To Equity: 1.77x
P/S TTM: 3.57x
P/B TTM: 2.75x
Market Cap: $43.34M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is ELUTIA INC. in?

ELUTIA INC. (ELUT) operates in the Biological Products, (No Diagnostic Substances) industry.

What is ELUT's market cap?

ELUTIA INC. (ELUT) has a market capitalization of $43.34M as of 2026-06-30.

What is ELUT's P/E ratio?

ELUTIA INC. (ELUT)'s trailing twelve month P/E ratio is 0.84x as of 2026-06-30.

What exchange does ELUT trade on?

ELUTIA INC. (ELUT) trades on the Nasdaq.

Where is ELUTIA INC. incorporated?

ELUTIA INC. is incorporated in DE.

ELUTIA INC.

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

ELUTIA INC. (ELUT) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Biological Products, (No Diagnostic Substances)

Wall Street's data.
Main Street's price.

ELUTIA INC. (ELUT) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Biological Products, (No Diagnostic Substances)

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.